Merck & Co

Merck is a giant pharmaceutical company. You may have seen commercials for Keytruda or Remicade, some of their most popular drugs. Interestingly, they also developed the first mumps, chickenpox, rubella, and hepatitis B vaccines—but those are history. Merck’s value has climbed steadily over the past year, from $50 to $80, and hasn’t even gotten close to its all-time high of $90 in 2000, indicative of stability. Moreover, Merck just acquired Immune Design, a company that is “harnessing the immune system to fight disease,” with promising and novel approaches to vaccinations.